Reflectance confocal microscopy to diagnose malignant melanoma and lentigo maligna in the UK: a single-centre prospective observational trial
British Journal of Dermatology · 23.12.2024 · 192 (1) · 27-35
DOI: 10.1093/bjd/ljae354 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift British Journal of Dermatology, online erschienen am 10.09.2024. Verfasst von Howard P Stevens und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Skin Care Network, Barnet, London, UK. Hauptthemen laut MEDLINE: Hutchinson's Melanotic Freckle, Skin Neoplasms, Microscopy, Confocal, Melanoma. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Mavig GmbH.
Abstract (Originalsprache)
Background
Previous work with reflectance confocal microscopy (RCM) has shown high sensitivity and specificity for malignant melanoma (MM); however, to date, there have been no studies with a UK cohort.
Objectives
To use RCM prospectively to accurately diagnose MM and lentigo maligna (LM) in a private UK secondary care, single-clinician setting; and to assess the potential of RCM to be used as a routine screening procedure.
Methods
In total, 597 patients with a differential clinical diagnosis of MM or LM were consecutively recruited. A sequential record was made of the clinical, dermoscopy and RCM findings by a single dermatologist prior to biopsy. Imaging was done with an arm-mounted confocal microscope unless there was restricted access to a lesion that required a handheld probe. The likelihood of MM was scored for each diagnostic modality, with each diagnosis building on the last. Histology was assessed by a single blinded histopathologist. The trial was registered with ClinicalTrials.gov (NCT03508297).
Results
Altogether, 733 lesions were included in the analysis, including 86 MM and LM (median diameter 7.0 mm). The benign-to-malignant ratio was 3 : 1 (nonmelanocytic malignancies included) and 8.3 : 1 for MM and LM only. The sensitivity and specificity for MM and LM, respectively, was 62.8% [95% confidence interval (CI) 51.7–73.0] and 63.1% (95% CI 59.3–66.8) for clinical examination; 91.9% (95% CI 84.0–96.7) and 42.0% (95% CI 38.1–45.9), respectively, for dermoscopy; and 94.2% (95% CI 87.0–98.1) and 83.0% (95% CI 79.9–85.8), respectively, for RCM. The positive predictive value of RCM in diagnosing MM and LM was 42.4% (95% CI 38.1–46.8) and the negative predictive value was 99.1% (95% CI 97.9–99.6).
Conclusions
This study demonstrates that RCM can reliably diagnose MM and is fast enough to be integrated into UK pigmented lesion clinics by dermatologists trained in RCM. The number needed to treat decreased from 3.86 with clinical examination to 2.96 with dermoscopy to 1.30 with RCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Skin Care Network, Barnet, London, UK.
- University La Sapienza, Rome, Italy.
- School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
- Cellular Pathology Services, Watford, UK.
ORCID-Profile: Colin Angus
Förderung
- Mavig GmbH
Zitieren
APA
Stevens, H. P., Pellacani, G., Angus, C., & El-Jabbour, J. N. (2024). Reflectance confocal microscopy to diagnose malignant melanoma and lentigo maligna in the UK: a single-centre prospective observational trial. British Journal of Dermatology, 192(1), 27-35. https://doi.org/10.1093/bjd/ljae354
Vancouver
Stevens HP, Pellacani G, Angus C, El-Jabbour JN. Reflectance confocal microscopy to diagnose malignant melanoma and lentigo maligna in the UK: a single-centre prospective observational trial. British Journal of Dermatology. 2024;192(1):27-35. doi:10.1093/bjd/ljae354
BibTeX
@article{Stevens2024,
author = {Stevens, Howard P and Pellacani, Giovanni and Angus, Colin and El-Jabbour, Joseph N},
title = {Reflectance confocal microscopy to diagnose malignant melanoma and lentigo maligna in the UK: a single-centre prospective observational trial},
journal = {British Journal of Dermatology},
year = {2024},
volume = {192},
number = {1},
pages = {27--35},
doi = {10.1093/bjd/ljae354}
}
EUVIMED